Clinical Trial: Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional

Official Title: Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2

Brief Summary: The purpose of this study is to assess the abuse liability and reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in heroin-dependent volunteers

Detailed Summary: not available at this time
Sponsor: University of Colorado, Denver

Current Primary Outcome:

  • Subjective dose estimate
  • Observed withdrawal rating
  • Opioid antagonist rating
  • Pupil diameter
  • Analog rating scale for drug effects
  • Drug effect characteristics
  • Drug/Money Preferences


Original Primary Outcome:

  • Analog rating scale for drug effects
  • Drug effect characteristics
  • Drug/Money Preferences
  • Subjective dose estimate
  • Observed withdrawal rating
  • Opioid antagonist rating
  • Pupil diameter


Current Secondary Outcome:

Original Secondary Outcome:

Information By: University of Colorado, Denver

Dates:
Date Received: September 20, 1999
Date Started: October 1999
Date Completion:
Last Updated: May 2, 2017
Last Verified: May 2017